Cargando…

Predictor factors for non-invasive mechanical ventilation failure in severe COVID-19 patients in the intensive care unit: a single-center retrospective study

BACKGROUND: During the COVID-19 pandemia, non-invasive mechanical ventilation (NIV) has been largely applied. Few data are available about predictors of NIV failure in critical COVID-19 patients admitted to ICU. The aim of this study is to analyze clinical and laboratory features able to predict non...

Descripción completa

Detalles Bibliográficos
Autores principales: Romanelli, Antonio, Toigo, Pietro, Scarpati, Giuliana, Caccavale, Angela, Lauro, Gianluigi, Baldassarre, Daniela, Oliva, Filomena, Lacava, Graziella, Pascale, Gabriele, Piazza, Ornella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853166/
https://www.ncbi.nlm.nih.gov/pubmed/37386578
http://dx.doi.org/10.1186/s44158-022-00038-7
Descripción
Sumario:BACKGROUND: During the COVID-19 pandemia, non-invasive mechanical ventilation (NIV) has been largely applied. Few data are available about predictors of NIV failure in critical COVID-19 patients admitted to ICU. The aim of this study is to analyze clinical and laboratory features able to predict non-invasive ventilation success in avoiding endotracheal intubation. METHODS: A retrospective observational study was performed in our COVID-19 ICU during a 6-month period. Demographic, clinical, laboratory, imaging, and outcome data were extracted from electronic and paper medical records and anonymously collected. RESULTS: Eighty-two severe COVID-19 patients were supported by NIV at ICU admission. The median PaO(2)/FiO(2) ratio was 125 [98.5–177.7]. NIV failed in 44 cases (53%). Patients who experienced NIV failure had a higher Charlson Comorbidity Index (median value 4) compared to those who were dismissed without endotracheal intubation (median 2, p < 0.0001). At Cox regression analysis, the Charlson Comorbidity Index represented a predictive factor related to NIV failure. PaO(2)/FiO(2), CPK, INR, and AT III at ICU admission showed a significant relationship with the outcome, when single variables were adjusted for the Charlson Comorbidity Index. CONCLUSION: The Charlson Comorbidity Index may be helpful to stratify patients’ risk of NIV failure in a severe COVID-19 population; even if this study, retrospective design does not allow definitive conclusions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s44158-022-00038-7.